Medpace Holdings (MEDP) News
What's actually happening: chronological and provenance-stamped. News is context, not a signal.
The percentage on each card is MEDP's move today, from the quote feed. It is the same figure on every headline, not the move on that headline's own date.

Here is how Medpace (MEDP) and Atea Pharmaceuticals, Inc. (AVIR) have performed compared to their sector so far this year.…

Medpace (MEDP) is well positioned to outperform the market, as it exhibits above-average growth in financials.…

CenterBook Partners LP lessened its stake in shares of Medpace Holdings, Inc. (NASDAQ: MEDP) by 31.1% in a recent quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor o…

The Madison Mid Cap Fund (Class I) returned -2.09% in the third quarter, compared to the Russell Midcap Index return of -3.00%. The top five contributors for the quarter were Gartner, Medpace Holdings, Ross Stores, Revvi…

Investors interested in stocks from the Medical Services sector have probably already heard of Concentra Group (CON) and Medpace (MEDP). But which of these two stocks presents investors with the better value opportunity …

Does Medpace (MEDP) have what it takes to be a top stock pick for momentum investors? Let's find out.…

Medpace (MEDP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.…

Medpace (MEDP) possesses solid growth attributes, which could help it handily outperform the market.…

Medpace (MEDP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.…

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.…

Medpace Holdings is downgraded from "Buy" to "Hold" due to decelerating growth metrics and underwhelming forward guidance. Q3 2026 Net New Business Awards rose just 10.6%, a sharp slowdown from Q2's 28.2% growth, signali…

Net new business awards reached $873 million in the third quarter. Ending backlog reached $3.2 billion, up 5.6% year over year.…

Medpace Holdings, Inc. ( MEDP ) Q3 2026 Earnings Call October 22, 2026 9:00 AM EDT Company Participants David Ruhe - Associate Director of Financial Planning & Analysis August Troendle - CEO, President & Chairman Kevin B…

Medpace NASDAQ: MEDP reported third-quarter 2026 revenue growth of 8.5% and record net new business awards, while management said the clinical research organization continues to see a strong operating environment marked …

Medpace (MEDP) came out with quarterly earnings of $4.84 per share, beating the Zacks Consensus Estimate of $4.45 per share. This compares to earnings of $3.86 per share a year ago.…

On October 21, 2026, Medpace Holdings Inc (MEDP) shares rose 6.4% to $662.48, continuing a strong upward trend that has seen the stock increase 21.4% over the p…

Medpace stock slipped late Wednesday despite beating third-quarter forecasts and issuing an above-Street view for 2026 earnings.…

CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the third quarter ended September 30, 2026. Third Quarter 2026 Financial Results Revenue for the three …

Investors interested in Medical Services stocks are likely familiar with Concentra Group (CON) and Medpace (MEDP). But which of these two stocks offers value investors a better bang for their buck right now?…

In the latest trading session, Medpace (MEDP) closed at $609.89, marking a -1.64% move from the previous day.…

Medpace Holdings is misunderstood due to its faster, cleaner backlog burn, which the market misinterprets as a growth ceiling rather than a quality upgrade. Q2 revenues rose 17.2% to $707.3M, with EBITDA margin improving…

Medpace (MEDP) concluded the recent trading session at $602.9, signifying a -2.84% move from its prior day's close.…

Argent Capital Management LLC lessened its holdings in Medpace Holdings, Inc. (NASDAQ: MEDP) by 5.3% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 56,996 shares …

In the closing of the recent trading day, Medpace (MEDP) stood at $622.11, denoting a +1% move from the preceding trading day.…

Investors with an interest in Medical Services stocks have likely encountered both Concentra Group (CON) and Medpace (MEDP). But which of these two stocks offers value investors a better bang for their buck right now?…

CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its third quarter 2026 financial results after the market close on Wednesday, October 21, 2026. The Compa…
Kept in their own lane. A press release is the company talking, not reporting.
Expected by Feb 16. Report dates come from the data provider's upcoming-earnings feed and are its estimate, not a date the company has set.

